VHL represents the most widely mutated gene in ccRCC, and CAMKK1, RORA, and TYK2 were identified as potential SL partners of VHL in this study (Fig. 3A, Supplementary Table 3). This evidence concerns the gene TYK2 and nonpapillary renal cell carcinoma.